PubMed:32253888
Annnotations
LitCovid-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-11 | NCBITaxon:11118 | denotes | Coronavirus |
T2 | 19-29 | SP_7 | denotes | SARS-CoV-2 |
T3 | 80-85 | NCBITaxon:10239 | denotes | viral |
T4 | 104-114 | SP_7 | denotes | SARS-CoV-2 |
T5 | 138-143 | NCBITaxon:10239 | denotes | virus |
T6 | 156-167 | NCBITaxon:11118 | denotes | coronavirus |
T7 | 180-188 | SP_7 | denotes | COVID-19 |
T8 | 199-210 | UBERON:0001004 | denotes | respiratory |
T9 | 357-363 | UBERON:0002405 | denotes | immune |
T10 | 357-372 | GO:0006955 | denotes | immune response |
T11 | 468-473 | NCBITaxon:10239 | denotes | viral |
T12 | 506-521 | GO:0045087 | denotes | innate immunity |
T13 | 513-521 | UBERON:0002405 | denotes | immunity |
T14 | 523-539 | CHEBI:26764 | denotes | steroid hormones |
T15 | 523-539 | CHEBI:26764 | denotes | steroid hormones |
T16 | 563-578 | GO:0000803 | denotes | sex chromosomes |
T17 | 600-613 | GO:0000805 | denotes | X chromosomes |
T18 | 637-650 | UBERON:0002405 | denotes | immune system |
T19 | 680-686 | UBERON:0002405 | denotes | immune |
T20 | 687-697 | GO:0065007 | denotes | regulatory |
T21 | 698-703 | SO:0000704 | denotes | genes |
T22 | 715-727 | GO:0000805 | denotes | X chromosome |
T23 | 758-763 | NCBITaxon:10239 | denotes | viral |
T24 | 807-810 | NCBITaxon:9606 | denotes | man |
T25 | 818-821 | PR:000001004 | denotes | CD4 |
T26 | 823-830 | CL:0000084 | denotes | T cells |
T27 | 854-860 | UBERON:0002405 | denotes | immune |
T28 | 854-869 | GO:0006955 | denotes | immune response |
T29 | 925-935 | GO:0042571 | denotes | antibodies |
T30 | 990-1003 | GO:0001775 | denotes | activation of |
T31 | 1008-1014 | UBERON:0002405 | denotes | immune |
T32 | 1008-1020 | CL:0000738 | denotes | immune cells |
T33 | 1095-1099 | PR:000001158 | denotes | TLR7 |
T34 | 1127-1131 | PR:000001158 | denotes | TLR7 |
T35 | 1171-1180 | SO:0001023 | denotes | biallelic |
T36 | 1181-1191 | GO:0010467 | denotes | expression |
T37 | 1208-1214 | UBERON:0002405 | denotes | immune |
T38 | 1208-1224 | GO:0006955 | denotes | immune responses |
T39 | 1257-1262 | NCBITaxon:10239 | denotes | viral |
T40 | 1275-1279 | PR:000001158 | denotes | TLR7 |
T41 | 1283-1292 | GO:0010467 | denotes | expressed |
T42 | 1296-1315 | CL:0000738 | denotes | innate immune cells |
T43 | 1303-1309 | UBERON:0002405 | denotes | immune |
T44 | 1333-1346 | SO:0001199 | denotes | single strand |
T45 | 1347-1356 | BV_22 | denotes | RNA virus |
T46 | 1351-1356 | NCBITaxon:10239 | denotes | virus |
T47 | 1388-1398 | GO:0042571 | denotes | antibodies |
T48 | 1411-1416 | NCBITaxon:10239 | denotes | virus |
T49 | 1476-1480 | PR:000001393 | denotes | IL-6 |
T50 | 1556-1560 | PR:000001393 | denotes | IL-6 |
T51 | 1567-1572 | NCBITaxon:10239 | denotes | viral |
T52 | 1675-1687 | GO:0000805 | denotes | X chromosome |
T53 | 1721-1726 | SO:0000704 | denotes | genes |
T54 | 1743-1753 | GO:0065007 | denotes | regulation |
T55 | 1757-1763 | UBERON:0002405 | denotes | immune |
T56 | 1757-1769 | CL:0000738 | denotes | immune cells |
T57 | 1778-1783 | PR:000001350 | denotes | FOXP3 |
T58 | 1831-1836 | NCBITaxon:10239 | denotes | virus |
T59 | 1855-1867 | GO:0000805 | denotes | X chromosome |
T60 | 1883-1896 | UBERON:0002405 | denotes | immune system |
T61 | 1941-1945 | PR:000001159 | denotes | TLR8 |
T62 | 1947-1952 | PR:000001950 | denotes | CD40L |
T63 | 1957-1962 | PR:000001207 | denotes | CXCR3 |
T64 | 1981-1990 | GO:0010467 | denotes | expressed |
T65 | 2031-2036 | NCBITaxon:10239 | denotes | viral |
T66 | 2079-2088 | SO:0001023 | denotes | biallelic |
T67 | 2089-2099 | GO:0010467 | denotes | expression |
T68 | 2107-2108 | GO:0000805 | denotes | X |
T69 | 2116-2121 | SO:0000704 | denotes | genes |
T70 | 2142-2152 | UBERON:0002405 | denotes | autoimmune |
T71 | 2181-2195 | UBERON:0004535 | denotes | Cardiovascular |
T72 | 2253-2267 | UBERON:0004535 | denotes | cardiovascular |
T73 | 2391-2396 | CHEBI:23888 | denotes | drugs |
T74 | 2391-2396 | CHEBI:23888 | denotes | drugs |
T75 | 2432-2451 | CHEBI:67079 | denotes | anti-inflammatories |
T76 | 2432-2451 | CHEBI:67079 | denotes | anti-inflammatories |
T77 | 2493-2503 | GO:0042571 | denotes | antibodies |
T78 | 2524-2528 | PR:000001393 | denotes | IL-6 |
T79 | 2545-2549 | CHEBI:23888 | denotes | drug |
T80 | 2545-2549 | CHEBI:23888 | denotes | drug |
T81 | 2560-2569 | CHEBI:22260 | denotes | adenosine |
T82 | 2560-2569 | CHEBI:22260 | denotes | adenosine |
T83 | 2597-2615 | CHEBI:5801 | denotes | hydroxychloroquine |
T84 | 2597-2615 | CHEBI:5801 | denotes | hydroxychloroquine |
T85 | 2597-2615 | DG_20 | denotes | hydroxychloroquine |
T86 | 2738-2743 | NCBITaxon:10239 | denotes | virus |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 637-650 | Body_part | denotes | immune system | http://purl.obolibrary.org/obo/UBERON_0002405 |
T2 | 1883-1896 | Body_part | denotes | immune system | http://purl.obolibrary.org/obo/UBERON_0002405 |
LitCovid_AGAC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
p124602s13 | 758-775 | MPA | denotes | viral load levels |
p124605s14 | 1201-1207 | PosReg | denotes | higher |
p124605s15 | 1208-1224 | MPA | denotes | immune responses |
p124605s18 | 1229-1238 | PosReg | denotes | increases |
p124605s20 | 1243-1273 | MPA | denotes | resistance to viral infections |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 523-539 | Body_part | denotes | steroid hormones | http://purl.org/sig/ont/fma/fma83353 |
T2 | 563-578 | Body_part | denotes | sex chromosomes | http://purl.org/sig/ont/fma/fma74407 |
T3 | 600-613 | Body_part | denotes | X chromosomes | http://purl.org/sig/ont/fma/fma84055 |
T4 | 637-650 | Body_part | denotes | immune system | http://purl.org/sig/ont/fma/fma9825 |
T5 | 715-727 | Body_part | denotes | X chromosome | http://purl.org/sig/ont/fma/fma84055 |
T6 | 825-830 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T7 | 1015-1020 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T8 | 1310-1315 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T9 | 1347-1350 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T10 | 1456-1465 | Body_part | denotes | cytokines | http://purl.org/sig/ont/fma/fma84050 |
T11 | 1485-1489 | Body_part | denotes | IL-1 | http://purl.org/sig/ont/fma/fma86583 |
T12 | 1675-1687 | Body_part | denotes | X chromosome | http://purl.org/sig/ont/fma/fma84055 |
T13 | 1764-1769 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T14 | 1855-1867 | Body_part | denotes | X chromosome | http://purl.org/sig/ont/fma/fma84055 |
T15 | 1883-1896 | Body_part | denotes | immune system | http://purl.org/sig/ont/fma/fma9825 |
T16 | 1921-1929 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T17 | 2510-2514 | Body_part | denotes | IL-1 | http://purl.org/sig/ont/fma/fma86583 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 19-27 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 80-95 | Disease | denotes | viral infection | http://purl.obolibrary.org/obo/MONDO_0005108 |
T3 | 86-95 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T4 | 104-112 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 180-188 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 193-228 | Disease | denotes | acute respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0006502 |
T7 | 199-228 | Disease | denotes | respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0009971 |
T8 | 383-392 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T9 | 397-418 | Disease | denotes | inflammatory diseases | http://purl.obolibrary.org/obo/MONDO_0021166 |
T10 | 468-484 | Disease | denotes | viral infections | http://purl.obolibrary.org/obo/MONDO_0005108 |
T11 | 786-798 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T12 | 1257-1273 | Disease | denotes | viral infections | http://purl.obolibrary.org/obo/MONDO_0005108 |
T13 | 1567-1582 | Disease | denotes | viral infection | http://purl.obolibrary.org/obo/MONDO_0005108 |
T14 | 1573-1582 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T15 | 2031-2047 | Disease | denotes | viral infections | http://purl.obolibrary.org/obo/MONDO_0005108 |
T16 | 2181-2204 | Disease | denotes | Cardiovascular diseases | http://purl.obolibrary.org/obo/MONDO_0004995 |
T17 | 2461-2479 | Disease | denotes | rheumatic diseases | http://purl.obolibrary.org/obo/MONDO_0005554 |
T18 | 2589-2594 | Disease | denotes | ebola | http://purl.obolibrary.org/obo/MONDO_0005737 |
T19 | 2638-2645 | Disease | denotes | malaria | http://purl.obolibrary.org/obo/MONDO_0005136 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 118-119 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T2 | 138-143 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T3 | 494-495 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T4 | 637-650 | http://purl.obolibrary.org/obo/UBERON_0002405 | denotes | immune system |
T5 | 698-703 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | genes |
T6 | 731-737 | http://purl.obolibrary.org/obo/UBERON_0003100 | denotes | female |
T7 | 818-821 | http://purl.obolibrary.org/obo/PR_000001004 | denotes | CD4 |
T8 | 823-830 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cells |
T9 | 990-1000 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
T10 | 1015-1020 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T11 | 1310-1315 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T12 | 1351-1356 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T13 | 1411-1416 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T14 | 1600-1605 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | males |
T15 | 1600-1605 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | males |
T16 | 1635-1636 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T17 | 1721-1726 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | genes |
T18 | 1764-1769 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T19 | 1778-1783 | http://purl.obolibrary.org/obo/PR_000001350 | denotes | FOXP3 |
T20 | 1814-1818 | http://purl.obolibrary.org/obo/CL_0000792 | denotes | Treg |
T21 | 1831-1836 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T22 | 1883-1896 | http://purl.obolibrary.org/obo/UBERON_0002405 | denotes | immune system |
T23 | 2116-2121 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | genes |
T24 | 2226-2231 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | males |
T25 | 2226-2231 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | males |
T26 | 2305-2306 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T27 | 2738-2743 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 523-539 | Chemical | denotes | steroid hormones | http://purl.obolibrary.org/obo/CHEBI_26764 |
T2 | 523-530 | Chemical | denotes | steroid | http://purl.obolibrary.org/obo/CHEBI_35341 |
T3 | 531-539 | Chemical | denotes | hormones | http://purl.obolibrary.org/obo/CHEBI_24621 |
T4 | 1476-1478 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T6 | 1485-1487 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T8 | 1556-1558 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T10 | 1921-1929 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T11 | 2391-2396 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T12 | 2510-2512 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T14 | 2524-2526 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T16 | 2545-2549 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T17 | 2560-2569 | Chemical | denotes | adenosine | http://purl.obolibrary.org/obo/CHEBI_16335 |
T18 | 2597-2615 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 199-219 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
T2 | 2181-2204 | Phenotype | denotes | Cardiovascular diseases | http://purl.obolibrary.org/obo/HP_0001626 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 80-95 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infection |
T2 | 357-372 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
T3 | 468-484 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infections |
T4 | 506-521 | http://purl.obolibrary.org/obo/GO_0045087 | denotes | innate immunity |
T5 | 786-798 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
T6 | 854-869 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
T7 | 1208-1224 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune responses |
T8 | 1257-1273 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infections |
T9 | 1296-1309 | http://purl.obolibrary.org/obo/GO_0045087 | denotes | innate immune |
T10 | 1567-1582 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infection |
T11 | 1743-1753 | http://purl.obolibrary.org/obo/GO_0065007 | denotes | regulation |
T12 | 1789-1809 | http://purl.obolibrary.org/obo/GO_0000981 | denotes | transcription factor |
T13 | 1789-1802 | http://purl.obolibrary.org/obo/GO_0006351 | denotes | transcription |
T14 | 1837-1849 | http://purl.obolibrary.org/obo/GO_0009405 | denotes | pathogenesis |
T15 | 2031-2047 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infections |
T16 | 2157-2179 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammatory responses |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-96 | Sentence | denotes | Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. |
T2 | 97-279 | Sentence | denotes | CoV-19/SARS-CoV-2 is a highly pathogenic virus that causes coronavirus-19 disease (COVID-19) an acute respiratory distress syndrome which provokes serious problems for global health. |
T3 | 280-419 | Sentence | denotes | Studies suggest that there are many differences between men and women in the immune response to CoV-19 infection and inflammatory diseases. |
T4 | 420-579 | Sentence | denotes | Women, compared to men, are less susceptible to viral infections based on a different innate immunity, steroid hormones and factors related to sex chromosomes. |
T5 | 580-675 | Sentence | denotes | The presence of two X chromosomes in women emphasize the immune system even if one is inactive. |
T6 | 676-870 | Sentence | denotes | The immune regulatory genes encoded by X chromosome in female gender causes lower viral load levels, and less inflammation than in man, while CD4+ T cells are higher with better immune response. |
T7 | 871-975 | Sentence | denotes | In addition, women generally produce higher levels of antibodies which remain in the circulation longer. |
T8 | 976-1126 | Sentence | denotes | The levels of activation of the immune cells are higher in women than in men, and it is correlated with the trigger of TLR7 and the production of IFN. |
T9 | 1127-1274 | Sentence | denotes | TLR7 is higher in women than in men and its biallelic expression leads to higher immune responses and increases the resistance to viral infections. |
T10 | 1275-1505 | Sentence | denotes | TLR7 is expressed in innate immune cells which recognizes single strand RNA virus by promoting the production of antibodies against the virus and the generation of pro-inflammatory cytokines including IL-6 and IL-1 family members. |
T11 | 1506-1654 | Sentence | denotes | Moreover, in women the production of inflammatory IL-6 after viral infection is lower than in males and is often correlated with a better longevity. |
T12 | 1655-1850 | Sentence | denotes | In addition, on the X chromosome there are loci that code for the genes involved in the regulation of immune cells such as FOXP3, and transcription factor for Treg involved in virus pathogenesis. |
T13 | 1851-2065 | Sentence | denotes | The X chromosome influences the immune system by acting on many other proteins, including TLR8, CD40L and CXCR3 which can be over-expressed in women, and influence the response to viral infections and vaccinations. |
T14 | 2066-2180 | Sentence | denotes | However, the biallelic expression of the X-linked genes can promote harmful autoimmune and inflammatory responses. |
T15 | 2181-2365 | Sentence | denotes | Cardiovascular diseases are more frequent in males and subjects without cardiovascular dysfunctions infected by CoV-19 have a better prognosis, but these effects are still under study. |
T16 | 2366-2744 | Sentence | denotes | It is hoped that certain drugs, such as CoV-19 receptor blockers, anti-inflammatories (against rheumatic diseases), monoclonal antibodies, anti-IL-1 and anti-IL-6, the remdesevir drug (analogue adenosine, effective against ebola), hydroxychloroquine (for the treatment of malaria) and vaccines, will open up new strategies and new therapeutic ways to combat this terrible virus. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
6 | 0-11 | Species | denotes | Coronavirus | Tax:11118 |
7 | 12-18 | Species | denotes | COV-19 | Tax:2697049 |
8 | 19-29 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
9 | 38-43 | Species | denotes | women | Tax:9606 |
10 | 54-57 | Species | denotes | men | Tax:9606 |
11 | 80-95 | Disease | denotes | viral infection | MESH:D001102 |
59 | 97-103 | Species | denotes | CoV-19 | Tax:2697049 |
60 | 104-114 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
61 | 156-170 | Species | denotes | coronavirus-19 | Tax:2697049 |
62 | 180-188 | Disease | denotes | COVID-19 | MESH:C000657245 |
63 | 193-228 | Disease | denotes | acute respiratory distress syndrome | MESH:D012128 |
64 | 336-339 | Species | denotes | men | Tax:9606 |
65 | 344-349 | Species | denotes | women | Tax:9606 |
66 | 376-392 | Disease | denotes | CoV-19 infection | MESH:D018352 |
67 | 420-425 | Species | denotes | Women | Tax:9606 |
68 | 439-442 | Species | denotes | men | Tax:9606 |
69 | 468-484 | Disease | denotes | viral infections | MESH:D001102 |
70 | 523-530 | Chemical | denotes | steroid | MESH:D013256 |
71 | 617-622 | Species | denotes | women | Tax:9606 |
72 | 786-798 | Disease | denotes | inflammation | MESH:D007249 |
73 | 818-821 | Gene | denotes | CD4 | Gene:920 |
74 | 884-889 | Species | denotes | women | Tax:9606 |
75 | 1035-1040 | Species | denotes | women | Tax:9606 |
76 | 1049-1052 | Species | denotes | men | Tax:9606 |
77 | 1095-1099 | Gene | denotes | TLR7 | Gene:51284 |
78 | 1122-1125 | Gene | denotes | IFN | Gene:3439 |
79 | 1127-1131 | Gene | denotes | TLR7 | Gene:51284 |
80 | 1145-1150 | Species | denotes | women | Tax:9606 |
81 | 1159-1162 | Species | denotes | men | Tax:9606 |
82 | 1257-1273 | Disease | denotes | viral infections | MESH:D001102 |
83 | 1275-1279 | Gene | denotes | TLR7 | Gene:51284 |
84 | 1476-1480 | Gene | denotes | IL-6 | Gene:3569 |
85 | 1485-1489 | Gene | denotes | IL-1 | Gene:3552 |
86 | 1519-1524 | Species | denotes | women | Tax:9606 |
87 | 1556-1560 | Gene | denotes | IL-6 | Gene:3569 |
88 | 1567-1582 | Disease | denotes | viral infection | MESH:D001102 |
89 | 1778-1783 | Gene | denotes | FOXP3 | Gene:50943 |
90 | 1941-1945 | Gene | denotes | TLR8 | Gene:51311 |
91 | 1947-1952 | Gene | denotes | CD40L | Gene:959 |
92 | 1957-1962 | Gene | denotes | CXCR3 | Gene:2833 |
93 | 1994-1999 | Species | denotes | women | Tax:9606 |
94 | 2031-2047 | Disease | denotes | viral infections | MESH:D001102 |
95 | 2181-2204 | Disease | denotes | Cardiovascular diseases | MESH:D002318 |
96 | 2253-2289 | Disease | denotes | cardiovascular dysfunctions infected | MESH:D002318 |
97 | 2293-2299 | Species | denotes | CoV-19 | Tax:2697049 |
98 | 2406-2412 | Species | denotes | CoV-19 | Tax:2697049 |
99 | 2461-2479 | Disease | denotes | rheumatic diseases | MESH:D012216 |
100 | 2510-2514 | Gene | denotes | IL-1 | Gene:3552 |
101 | 2524-2528 | Gene | denotes | IL-6 | Gene:3569 |
102 | 2560-2569 | Chemical | denotes | adenosine | MESH:D000241 |
103 | 2589-2594 | Species | denotes | ebola | Tax:1570291 |
104 | 2597-2615 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
105 | 2638-2645 | Disease | denotes | malaria | MESH:D008288 |
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-96 | Sentence | denotes | Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. |
T2 | 97-279 | Sentence | denotes | CoV-19/SARS-CoV-2 is a highly pathogenic virus that causes coronavirus-19 disease (COVID-19) an acute respiratory distress syndrome which provokes serious problems for global health. |
T3 | 280-419 | Sentence | denotes | Studies suggest that there are many differences between men and women in the immune response to CoV-19 infection and inflammatory diseases. |
T4 | 420-579 | Sentence | denotes | Women, compared to men, are less susceptible to viral infections based on a different innate immunity, steroid hormones and factors related to sex chromosomes. |
T5 | 580-675 | Sentence | denotes | The presence of two X chromosomes in women emphasize the immune system even if one is inactive. |
T6 | 676-870 | Sentence | denotes | The immune regulatory genes encoded by X chromosome in female gender causes lower viral load levels, and less inflammation than in man, while CD4+ T cells are higher with better immune response. |
T7 | 871-975 | Sentence | denotes | In addition, women generally produce higher levels of antibodies which remain in the circulation longer. |
T8 | 976-1126 | Sentence | denotes | The levels of activation of the immune cells are higher in women than in men, and it is correlated with the trigger of TLR7 and the production of IFN. |
T9 | 1127-1274 | Sentence | denotes | TLR7 is higher in women than in men and its biallelic expression leads to higher immune responses and increases the resistance to viral infections. |
T10 | 1275-1505 | Sentence | denotes | TLR7 is expressed in innate immune cells which recognizes single strand RNA virus by promoting the production of antibodies against the virus and the generation of pro-inflammatory cytokines including IL-6 and IL-1 family members. |
T11 | 1506-1654 | Sentence | denotes | Moreover, in women the production of inflammatory IL-6 after viral infection is lower than in males and is often correlated with a better longevity. |
T12 | 1655-1850 | Sentence | denotes | In addition, on the X chromosome there are loci that code for the genes involved in the regulation of immune cells such as FOXP3, and transcription factor for Treg involved in virus pathogenesis. |
T13 | 1851-2065 | Sentence | denotes | The X chromosome influences the immune system by acting on many other proteins, including TLR8, CD40L and CXCR3 which can be over-expressed in women, and influence the response to viral infections and vaccinations. |
T14 | 2066-2180 | Sentence | denotes | However, the biallelic expression of the X-linked genes can promote harmful autoimmune and inflammatory responses. |
T15 | 2181-2365 | Sentence | denotes | Cardiovascular diseases are more frequent in males and subjects without cardiovascular dysfunctions infected by CoV-19 have a better prognosis, but these effects are still under study. |
T16 | 2366-2744 | Sentence | denotes | It is hoped that certain drugs, such as CoV-19 receptor blockers, anti-inflammatories (against rheumatic diseases), monoclonal antibodies, anti-IL-1 and anti-IL-6, the remdesevir drug (analogue adenosine, effective against ebola), hydroxychloroquine (for the treatment of malaria) and vaccines, will open up new strategies and new therapeutic ways to combat this terrible virus. |
T1 | 0-96 | Sentence | denotes | Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. |
T2 | 97-279 | Sentence | denotes | CoV-19/SARS-CoV-2 is a highly pathogenic virus that causes coronavirus-19 disease (COVID-19) an acute respiratory distress syndrome which provokes serious problems for global health. |
T3 | 280-419 | Sentence | denotes | Studies suggest that there are many differences between men and women in the immune response to CoV-19 infection and inflammatory diseases. |
T4 | 420-579 | Sentence | denotes | Women, compared to men, are less susceptible to viral infections based on a different innate immunity, steroid hormones and factors related to sex chromosomes. |
T5 | 580-675 | Sentence | denotes | The presence of two X chromosomes in women emphasize the immune system even if one is inactive. |
T6 | 676-870 | Sentence | denotes | The immune regulatory genes encoded by X chromosome in female gender causes lower viral load levels, and less inflammation than in man, while CD4+ T cells are higher with better immune response. |
T7 | 871-975 | Sentence | denotes | In addition, women generally produce higher levels of antibodies which remain in the circulation longer. |
T8 | 976-1126 | Sentence | denotes | The levels of activation of the immune cells are higher in women than in men, and it is correlated with the trigger of TLR7 and the production of IFN. |
T9 | 1127-1274 | Sentence | denotes | TLR7 is higher in women than in men and its biallelic expression leads to higher immune responses and increases the resistance to viral infections. |
T10 | 1275-1505 | Sentence | denotes | TLR7 is expressed in innate immune cells which recognizes single strand RNA virus by promoting the production of antibodies against the virus and the generation of pro-inflammatory cytokines including IL-6 and IL-1 family members. |
T11 | 1506-1654 | Sentence | denotes | Moreover, in women the production of inflammatory IL-6 after viral infection is lower than in males and is often correlated with a better longevity. |
T12 | 1655-1850 | Sentence | denotes | In addition, on the X chromosome there are loci that code for the genes involved in the regulation of immune cells such as FOXP3, and transcription factor for Treg involved in virus pathogenesis. |
T13 | 1851-2065 | Sentence | denotes | The X chromosome influences the immune system by acting on many other proteins, including TLR8, CD40L and CXCR3 which can be over-expressed in women, and influence the response to viral infections and vaccinations. |
T14 | 2066-2180 | Sentence | denotes | However, the biallelic expression of the X-linked genes can promote harmful autoimmune and inflammatory responses. |
T15 | 2181-2365 | Sentence | denotes | Cardiovascular diseases are more frequent in males and subjects without cardiovascular dysfunctions infected by CoV-19 have a better prognosis, but these effects are still under study. |
T16 | 2366-2744 | Sentence | denotes | It is hoped that certain drugs, such as CoV-19 receptor blockers, anti-inflammatories (against rheumatic diseases), monoclonal antibodies, anti-IL-1 and anti-IL-6, the remdesevir drug (analogue adenosine, effective against ebola), hydroxychloroquine (for the treatment of malaria) and vaccines, will open up new strategies and new therapeutic ways to combat this terrible virus. |
hydroxychloroquine
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 199-219 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
T2 | 2181-2204 | Phenotype | denotes | Cardiovascular diseases | http://purl.obolibrary.org/obo/HP_0001626 |
LitCovid_AGAC_only
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
p5785s15 | 149-155 | Reg | denotes | causes |
p5785s16 | 156-167 | Disease | denotes | coronavirus |
p5792s14 | 1201-1207 | PosReg | denotes | higher |
p5792s15 | 1208-1224 | MPA | denotes | immune responses |
p5792s18 | 1229-1238 | PosReg | denotes | increases |
p5792s20 | 1243-1253 | MPA | denotes | resistance |